Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Opiant Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 31 | 26 | −5 |
| Shares | 913.8K | 877.8K | −36.1K (−3.9%) |
| Value | $9.70M | $11.8M | +$2.06M (+21.3%) |
New holders (1)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 1,195 | $16.0K | 0.00% |
Sold out (6)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citadel Advisors LLC | 11,110 | $118.0K |
| Bank of Montreal | 2,025 | $21.0K |
| Mesirow Financial Investment Management, Inc. | 753 | $8.00K |
| Certified Advisory Corp | 500 | $5.00K |
| FMR LLC | 200 | $2.00K |
| Wealthcare Capital Management LLC | 15 | $0 |